Reardon Andrewinsider trades
In SEC Form 4 filings, Reardon Andrew is listed as CLO & Secretary of Ligand Pharmaceuticals Inc (LGND). In the last 90 days, Reardon Andrew sold $2.95M of Ligand Pharmaceuticals Inc (LGND) on the open market and bought none. All 11 sales were reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| LGNDLigand Pharmaceuticals Inc | CLO & Secretary | 13 | Oct 6 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-08
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| LGNDLigand Pharmaceuticals Inc | Oct 2 | Oct 6 | M | 340 | $52.27 | $17,772 | 36,854 | Yes | Form 4 |
| LGNDLigand Pharmaceuticals Inc | Oct 2 | Oct 6 | S | 833 | $302.51 | Sale −$251,991 | 36,021 | Yes | Form 4 |
| LGNDLigand Pharmaceuticals Inc | Oct 2 | Oct 6 | S | 1,976 | $303.54 | Sale −$599,804 | 34,045 | Yes | Form 4 |
| LGNDLigand Pharmaceuticals Inc | Oct 2 | Oct 6 | S | 1,535 | $304.52 | Sale −$467,431 | 32,510 | Yes | Form 4 |
| LGNDLigand Pharmaceuticals Inc | Oct 2 | Oct 6 | S | 404 | $306.18 | Sale −$123,698 | 32,106 | Yes | Form 4 |
| LGNDLigand Pharmaceuticals Inc | Oct 2 | Oct 6 | S | 235 | $307.19 | Sale −$72,190 | 31,871 | Yes | Form 4 |
| LGNDLigand Pharmaceuticals Inc | Oct 2 | Oct 6 | S | 17 | $307.74 | Sale −$5,232 | 31,854 | Yes | Form 4 |
| LGNDLigand Pharmaceuticals Inc | Oct 2 | Oct 6 | M · derivative | 340 | $52.27 | $17,772 | 29,104 | Yes | Form 4 |
| LGNDLigand Pharmaceuticals Inc | Sep 3 | Sep 8 | S | 300 | $283.99 | Sale −$85,196 | 41,214 | Yes | Form 4 |
| LGNDLigand Pharmaceuticals Inc | Sep 3 | Sep 8 | S | 1,800 | $285.17 | Sale −$513,301 | 39,414 | Yes | Form 4 |
| LGNDLigand Pharmaceuticals Inc | Sep 3 | Sep 8 | S | 2,115 | $286.36 | Sale −$605,649 | 37,299 | Yes | Form 4 |
| LGNDLigand Pharmaceuticals Inc | Sep 3 | Sep 8 | S | 385 | $287.53 | Sale −$110,697 | 36,914 | Yes | Form 4 |
| LGNDLigand Pharmaceuticals Inc | Sep 3 | Sep 8 | S | 400 | $288.98 | Sale −$115,592 | 36,514 | Yes | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.